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 Introduction 
Mental illness causes as much of the misery in Britain today as poverty does (see Annex 
1).  It is our great hidden problem - little discussed because of the shame which surrounds 
it.  Some 16% of all adults have a diagnosable condition of clinical depression or anxiety 
disorder.1  Yet only a quarter of these are in treatment. 
This is a huge problem involving massive suffering and major economic cost.  So 
why is there so much untreated illness?  The main reason is simple.  The majority of 
patients with these problems who present in GP surgeries are only offered medication and 
it is what the majority of patients in treatment are receiving.2  But the majority of those 
who go to the doctor with these problems would prefer psychological therapy.  This 
emerges clearly from every survey of patient preferences.3  The evidence also shows that 
the majority of those who prefer psychological therapy choose not to get treated at all 
rather than go on medication.  So we have massive under-treatment due to the poor 
availability of psychological therapy.  
This would not matter much if psychological treatment was an inferior treatment.  
But hundreds of clinical trials for depression and anxiety disorders show that modern 
evidence-based treatments, especially cognitive behavioural therapy (CBT), are as 
effective as drugs in the short run, and more effective at preventing relapse (unless drugs 
continue to be taken indefinitely).  For these reasons NICE Guidelines say that, unless 
their condition is very recent, all these patients should be offered the choice of CBT.4  
CBT is a talking therapy in which patients are given tools to control their feelings 
including the ability to challenge negative thoughts and beliefs, and to cultivate positive 
thinking and action.  Normally treatment does not involve more than 16 sessions.  In 
some cases NICE also recommend other therapies. 
But unfortunately the Guidelines are simply not implemented, due to lack of 
therapists within the NHS.  This is the clearest breach of any of the NICE Guidelines for 
any illness affecting large numbers of people.  It also represents the greatest gap between 
best practice and actual practice anywhere in the NHS and it affects millions. 
That it continues is wrong in medical terms.  But it is also a major economic issue 
– which is what this article is about.  Depression and anxiety make it much more difficult 
for a person to work.  There is thus a substantial loss of output.  There is also a major cost 
to the Exchequer since about one million people are on incapacity benefits due to 
depression or anxiety disorders and it costs the Exchequer £750 for each month that 
someone is on these benefits rather than working. 
 These economic costs add weight to the humanitarian argument for implementing 
the NICE Guidelines.  Because of them, there is now major government interest in 
proposals to implement the Guidelines by a major expansion of psychological therapy 
within the NHS.  In its 2005 Election Manifesto the Labour Party committed itself to 
such a major expansion.  But the scale and speed with which it happens depends in part 
on the strength of the economic case for doing it. 
                                                 
1 ONS Psychiatric Morbidity Survey. Under 1% have psychotic disorders, which are not covered by this 
paper. 
2 See ONS Psychiatric Morbidity Survey. 
3 For a survey of the studies see van Schaik et al. (2004). See also Chilvers et al (2001). 
4 The National Institute for Health and Clinical Excellence (NICE) have produced separate guidelines for 
each of the main conditions, see their website. 
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 This case rests on the standard comparison of costs and benefits.  The cost of 
providing a standard course of CBT is £750, which provides for roughly 10 meetings – a 
reasonable average which allows for the usual drop-outs and a range of durations of 
treatment.5  To estimate the benefits, we draw not on one particular experiment but on a 
wide range of evidence from Britain and elsewhere (and not on one particular 
experiment). 
 The question is: What would be the impact of implementing the NICE Guidelines 
for a representative sample of people who have depression and/or anxiety disorders?  To 
answer it, we address in sequence the following questions: 
 
1.      If people are treated for a disorder, what percentage are cured (above natural 
recovery)? 
 2.      If people are cured, how much more work do they do? 
3.      As a result, how much benefit accrues to society as a whole (including the 
patient) and to the Exchequer? 
 
We then compare these benefits with the cost.  Our conclusions are that the benefits to 
the economy will exceed the costs, and that the savings to the Exchequer will exceed the 
Exchequer costs, possibly within two years of the treatment and certainly within five. 
 
 
1.  The Effects of Treatment on Health 
 
For purposes of the analysis, we focus on the effect of taking into treatment a 
representative sample of patients who would otherwise have no treatment.6  We begin 
with the impact on their health. 
As Table 1 shows, some 82% of those who begin treatment will persevere with it 
and of these 61% will recover within 4 months (ie they will cease to be diagnosed as a 
‘case’ of the disorder).  But some sufferers would recover in any event, so that the net 
effect of treatment on recovery is that shown in column (4) of the table. 
This table is based on judgment and reflects hundreds of clinical trials.  It is 
sometimes alleged that, when therapies are used in the ‘field’, the success rates are lower 
than in the clinical trials.  This is not necessarily the case.7  But, to be on the safe side, we 
use success rates in Table 1 that are well below those obtained in the most successful 
                                                 
5 Curtis and Netten (2006) give a £66 cost per session, but the NICE Guidelines for PTSD gives an £82 cost 
per session.  We envisage that some sessions would use computerised CBT or less intensive methods than 
one-to-one face-to-face one-hour sessions, thus reducing the cost.  Our estimate also allows for the 
amortised cost of CBT training. 
6 The weights given to the different conditions are shown in Annex 2. 
7 The following five articles report field results of CBT where success rates were comparable with standard 
clinical trials.  (Clinical trals are generally confined to patients with only one condition which in the field 
many patients have multiple conditions.) The results cover social phobia, anxiety and depression, 
agoraphobia, panic disorder and PTSD.  See Lincoln et al (2003), Persons et al (2005), Hahlweg  et al 
(2001), Wade et al (1998) and Gillespie et al (2002). 
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clinical trials.8  The assumptions made were endorsed at a one-day conference of leading 
experts held at the Department of Health in May 2006. 
The table highlights the power of CBT, compared with no treatment.  For both 
depression and anxiety disorders it is at least as effective as drugs during the treatment 
phase, but it is more effective than drugs in preventing relapse unless drugs are taken 
continuously9.  Figure 1 illustrates this point.10 
Thus the effect of treatment involves not simply whether the person recovers but 
how long he is well rather than ill, as a result of the treatment.  This is examined in the 
first two columns of Table 2.  Here we allow for two important points: that natural 
recovery goes on beyond 4 months, while at the same time some cured patients relapse 
into illness.  The conclusion is that, in the 2 years after treatment ends, a treated patient 
will spend 6.5 months extra being well. In the longer period of 5 years, he will spend 13.1 
months extra being well. 
Thus there are substantial gains in healthy life, which relieves suffering.  But what 
is the effect of this extra health upon employment? 
 
 
2.  Effect of Health upon Employment  
 
To find the effect of health on employment, there are two possible sources of evidence:  
cross-sectional and longitudinal.  We use both kinds, beginning with cross-sectional.   
Table 3 is from the Psychiatric Morbidity Survey.  As it shows, 51% of the 
mentally ill group are in employment, compared with 74% of those who are well – a 
difference of 23 percentage points.  It would be unreasonable to assume that, if the same 
individual moves from mental illness to health, his probability of employment changes by 
the full difference of 23 percentage points; for there may be other reasons for his non-
employment which continue to operate when his mental illness is cured.  We therefore 
assume that the actual change will be 60% of the simple difference – that is 14 percentage 
points.11  
 We can now revert to Table 2 to find the overall effect of treatment on 
employment.  This is shown in Columns (4) and (5).  The implication is that, following 
treatment, a person can expect on average to work 0.99 extra months in the following two 
years.  If we consider the whole period of five years, the expected effect is roughly twice 
as large. 
 These effects come about in two ways:  A mentally ill person with a job may risk 
losing it; timely treatment can prevent this; equally, those who are out of work due to 
mental illness become more likely to work if they recover from their illness. 
                                                 
8 These are summarised by Pilling and Clark in Annexes A1 and A2 of Department of Health, An Outline 
Business Case for the National Roll-Out of Local Psychological Therapy Services. 
9 This means that if we simply replaced ongoing drug treatment by one-off CBT there would be little 
predictable change in health outcomes, nor in cost.  That is one reason why our analysis focuses on getting 
more people treated. But the main reason for this is that we want more people to be treated. 
10 This figure is based on quite small sample numbers.  For the first 16 months the profiles are very similar 
to those in the larger samples studied by Paykel et al. (1999). 
11 This is a conservative assumption, for it does not allow for employment support of the kind envisaged in 
government proposals. This support would of course also add to the cost. 
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In addition, even if they do not lose their job, mentally ill workers are more likely 
to take time off sick, which imposes a significant economic cost.  As Table 4 shows, 
workers who are mentally ill take more days off sick than workers who are well.  The 
difference is 20 days per year.  We can again assume that, if a once-sick person is well, 
his absence is reduced by 60% of this figure, that is 12 days a year. 
So what is the overall effect of treatment on work, via its effect on absenteeism?  
Treatment raises healthy months by 27% (= 6.5/24).  Half the treated population is 
employed.  And over a two year period they work an extra 24 days, equivalent to 1.2 
months of work.  So the total increase in work per person treated is 0.15 months (= 1.2 x 
.27 x .5).  This represents a significant addition to the extra 0.99 months of employment 
recorded earlier. 
 
 
3.  Longitudinal Evidence 
 
All of these estimates are based on cross-sectional evidence.  What confidence can we 
have that we would get the same effects if we treated someone and followed his progress 
longitudinally?  There are a number of longitudinal studies which we can compare with 
our own assumptions.12   
For these purposes it is convenient to first summarise our assumptions, as follows.  
For people who are previously ill and receive treatment, we assume the following 
changes (for the two-year period after treatment): 
 
 Employment rate increased by 4 percentage points (= 0.99/24)  
 Absenteeism reduced by 3 days per year per worker (= 12 x 6.5/24). 
 
How do these estimates compare with the longitudinal evidence, most of which 
comes from the US.13  Two random assignment trials have traced the impact of treatment 
on employment.  In one trial depressed patients were given enhanced mental health 
treatment,14 and compared with controls who received treatment as usual (Wells et al, 
2000).  The effect of enhanced treatment was to raise the employment rates 12 months 
later by 5 percentage points – similar to our own estimates. 
In another random control trial patients with general anxiety disorder and/or panic 
disorder were given “collaborative mental health care” and compared with treatment as 
usual (Rollman et al, 2005).15  The effect of the special treatment was to raise the 
                                                 
12 None of the enhanced interventions studied is more substantial than the intervention we are proposing. 
13 This is a conservative assumption for it does not allow for employment support of the kind envisaged in 
government proposals. This support would of course also add to the cost. 
14 “Matched clinics were randomized to usual care (mailing of practice guidelines) or to 1 of 2 Quality 
Improvement programs that involved institutional commitment to Quality Improvement, training local 
experts and nurse specialists to provide clinician and patient education, identification of a pool of 
potentially depressed patients, and either nurses for medication follow-up or access to trained 
psychotherapists.” 
15 “Patients were randomly assigned to a telephone-based care management intervention or to notification 
alone of the anxiety disorder to patients and their physicians. The intervention involved non-mental health 
professionals who provided patients with psychoeducation, assessed preferences for guideline-based care, 
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employment rate 12 months later by 15 percentage points, and to reduce the absenteeism 
rate 12 months later by the equivalent of 31 days a year – both much bigger impacts than 
we have allowed for. 
A small British study by David Clark also found absenteeism effects greater than 
we have allowed for.  At the Centre for Anxiety Disorders and Trauma in Camberwell, 
patients were asked to fill in an employment questionnaire before and after CBT 
treatment.  122 patients completed the questionnaire.  One question was “How many days 
have you had off sick in the last month?”  Among those employed the average days per 
month off sick after treatment were 1.6 less than before treatment – an annual rate of 19 
days. 
The treatment effects discussed above combine the effect of treatment on health 
and the effect of health on employment.  One further US study enables us to study the 
second of these links in the chain: from health to employment.  This study covered people 
treated for depression with anti-depressants, and compared for the next two years the 
employment rate of those cured with those not cured (Simon et al, 2000).  The difference 
was 15 percentage points - close to our assumption of 14 points.  (That causality runs 
mainly from health to employment, and not vice versa, is shown by timing effects (Mintz 
et al, 1992)).16  The study also found that becoming healthy reduces a worker’s 
absenteeism by 12 days a year – exactly the same as the figure we assume. 
So our assumptions about the employment effects of treatment appear quite 
reasonable in the light of the longitudinal evidence.  Note that we are not claiming huge 
effects.  We are saying that people who are treated are in consequence 4 percentage 
points more likely to be in work over the next two years.  Clearly, if a person is cured of a 
chronic illness the effects last longer than this, and are thus greater.  But we want to be 
conservative and ignore these longer term effects. (For one thing we are interested in the 
immediate savings to the Treasury.)  We thus focus on employment effects which are 
quite small but, as we shall see, remarkably valuable relative to the cost. 
 
 
4.  Valuing the Benefits 
 
Output effects 
 
So what is the value of these benefits in employment?  We assume (in line with DWP 
practice) that a previously disabled person who works earns on average an annual wage 
of £12,000 – or £1,000 a month.  (This is a conservative assumption since the Labour 
Force Survey shows that employees who report ‘depression, bad nerves or anxiety’ earn 
on average £18,200 a year.)  Thus the extra GDP produced by treating one person is 
£1,100, the extra earnings from 1.1 extra months of work.  This compares with the 
treatment cost of £750 (see Table 5). 
 
 
                                                                                                                                                 
monitored treatment responses, and informed physicians of their patients’ care preferences and progress via 
an electronic medical record system under the direction of study investigators.” 
16  This meta-study looked at 8 studies (using different treatments) which gave data on the timing of 
changes in health and in employment. 
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Savings to the NHS 
 
There are also economic savings through reduced uses of resources within the NHS – 
both on the physical health side and the mental health side.  On the physical side there are 
at present many unnecessary referrals to the acute sector for conditions that are not 
“medically explicable” – sometimes estimated as half of all referrals to the acute sector 
(Nimnuan et al, 2001).  In the USA it has been found that people suffering from anxiety 
cost roughly $350 a year more than other people in terms of non-psychiatric medical 
costs (Greenberg et al, 1993, 2000).  If the position was similar in Britain for all 
conditions, the savings per person treated would be roughly £100 (within the first two 
years). 
There would also be important NHS savings on the mental health side – reduced 
referrals to the secondary sector and inpatient admissions, fewer visits to GPs and 
counselling sessions, and less medication.  In one study, referrals to secondary mental 
health services fell by almost 80% when GPs could refer patients to a CCBT clinic 
nearby, and they returned to their original level when the facility was withdrawn.17   
Our knowledge in this whole area is weak.  But we include in Table 5 the guess 
that the overall savings to the NHS per person treated is £300 over a two year period – 
including both physical and mental health services. 
 
Reduced suffering 
 
Finally, we must of course value the reduction in suffering, which we can measure by the 
change in Quality-Adjusted Life Years (QALYs).  We assume that the change in QALYs 
for each additional year of mental health is 0.2 QALYs.18  The expected gain in healthy 
life per person treated is 0.55 years in the subsequent two years – a gain of 0.11 QALYs.  
If we value a QALY at £30,000, as implied in much NICE discourse, this implies gains in 
QALYs worth £3,300 per person treated.  On this basis the total gains to society per 
person treated are £4,700 – far exceeding the cost (see Table 5). 
 
Savings to the Exchequer 
 
A quite different issue is the gains to the Exchequer.  These include: 
 
(a) the fiscal impact of increased employment, through reduced 
benefit  payments and increased tax receipts, and 
(b) the savings in NHS costs. 
 
                                                 
17 Information from Isaac Marks – see Marks et al (2003). 
18 According to the standard method of calculating QALYs, a person who is otherwise healthy but on the 
dimension of anxiety/depression reports ‘some problems, moderately anxious or depressed’ is given a 
QALY of 0.794 compared with 1.000 for someone who is completely healthy.  This yields a QALY deficit 
of roughly 0.2.  However, many people who suffer from anxiety/depression also suffer on one of the 2 
other Euroqual dimensions of illness (mobility, self-care, usual activities and pain/discomfort) – in which 
case the marginal impact of moderately anxious or depressed is roughly 0.1.  However we know that many 
of those other symptoms are due to mental illness, so we use the figure of 0.2.  The figure is also consistent 
with the findings of Revicki et al (1998). 
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As we have noted, there are two main ways in which therapy can affect the numbers in 
employment and on IB.  It can affect the flow of people out of employment and onto IB, 
and the flow of people out of IB and into employment.  The net effect of these two effects 
can be seen in the total stocks of people in employment and on IB. 
In Table 3 we can see how profound the impact is.  It shows what proportion of 
the mentally ill are on Incapacity Benefits or Income Support, as compared with those not 
mentally ill.  The difference is 30 percentage points.  As before, we assume that if a 
person ceases to be ill the effect on his propensity to be on IB/IS is 60 per cent of that – 
that is 18 percentage points.  So if a person is treated and spends 6.5 fewer months being 
ill, he will on average spend 1.17 fewer months on IB. 
In line with DWP figures, we assume that the benefits paid per disabled person 
are £6,000 per year (including incapacity benefit, income support, housing benefit and 
council tax benefit), and that a person earning £12,000 a year generates £3,000 a year 
extra in NI, Income Tax and consumption taxes.  This makes a cost per person on benefit 
of £9,000 a year – or £750 a month. 
Thus the gains to the Exchequer when an extra person is treated are £900 in 
financial savings, plus NHS savings on top of that.  This is well above the cost of £750. 
And it only covers the first two years. 
 
Longer-term effects on IB 
 
However, when a person is cured of a chronic illness, the effects last longer than two 
years.  These longer-term gains are more speculative but highly relevant.  The figures in 
Table 2 imply that the savings on IB over 5 years will be at least double what they are 
over 2 years.  Thus even if our estimates of the employment effects of better health 
were reduced by a half, the programme would still pay for itself over 5 years. 
The government is of course interested in aggregate effects as well as effects per 
person treated.  How far will the programme contribute to the objective of reducing the 
numbers on incapacity benefits by 1 million by 2016?  It appears that the Pathways to 
Work interviews and return to work bonuses have made little difference to the number of 
mentally ill people leaving IB.19  This shows the enormous importance of providing 
psychological therapies which can produce lasting changes in people and can also help to 
prevent them coming on to IB.   
The programme proposed in the LSE Depression Report envisaged a build up 
over a 6-year period, beginning in 2008/9 and reaching full-scale operation in 2013/4.20  
By that year 800,000 people would be receiving therapy each year.  This corresponds to 
about one quarter of those who present at GP surgeries each year with mental health 
problems.  It is also consistent with more detailed estimates based on the Psychiatric 
Morbidity Survey (Boardman and Parsonage, 2007).  Current Department of Health 
proposals for the Comprehensive Spending Review also reflect similar thinking.  They 
envisage a local psychological therapy service in every Primary Care Trust area, to which 
GPs could refer their patients or patients could refer themselves.  The service would 
include some 30-60 therapists, the majority of whom would have had at least one year’s 
                                                 
19 DWP Research Report No 354, p53. See also article by Richard Dorsett in this current issue. 
20 LSE Centre for Economic Performance, The Depression Report. A New Deal for Depression and Anxiety 
Disorders. June 2006. 
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training in CBT.  The service would also include support staff with expertise in 
employment, benefits and housing.  The team would have a physical centre but most of 
the care would be done on an outreach basis, for example in GP surgeries.  
In Table 6 we estimate how such a programme would impact on the number on 
IB.  The calculations are done on the assumption that all those treated receive standard 
treatment (costing around £750), leading to employment effects of the kind experienced 
in the past.  This is not quite right.  First, some will receive less intensive treatment (for 
less severe conditions).  But, second, the new service will be much more employment-
oriented than in the past.  
Assuming these two differences cancel out the proposed programme will reduce 
the numbers of mentally ill people on incapacity benefits by 160,000 by 2016.  This is 
less than proportional to the share of mentally ill people in the IB total.  But, even so, it 
will in that year save the Exchequer £1.4 billion a year – not bad for a programme costing 
£0.4 billion a year.  
 
 
5.  Conclusion 
 
Our analysis relates to the expected benefits from a standard treatment costing £750 per 
patient treated.  We mainly look at benefits per patient over the first two years after 
treatment ends. 
 
1. The extra GDP produced over those two years is likely to be around £1,200, and 
society will also gain from NHS savings of perhaps £300 and reduced suffering 
valued (on NICE criteria) at around £3,300.  These gains far exceed the cost of £750. 
 
2. The gain to the Exchequer is likely to be around £900 plus the NHS savings of 
perhaps £300.  Thus the cost is fully repaid. 
 
If, instead, we look at longer-term gains we find the following. 
 
3. Even if we halve our assumptions about the effect of improved mental health on 
employment, the treatment will pay for itself. 
 
4. By 2016 the new service would have reduced numbers on IB by 160,000, thus 
saving £1.4 billion a year to the Exchequer.  The cost of the service will by then 
be £0.4 billion a year. 
 
The fundamental reason for the excess of benefit over cost is the high cost of a person on 
IB (£750 a month) and the low cost of treatment per person (a one-off £750).  
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Table 1 
Effectiveness of CBT in first 4 months (%) 
 
 Retention rate Recovery rate 
Natural 
recovery rate 
Change in per cent 
who recover 
  (1) (2) (3) (4) 
Depression 80 60 30 24 
Phobia 85 70 5 55 
Obsessive-compulsive disorder 80 55 5 40 
Panic disorder 90 75 5 63 
General anxiety disorder 80 50 20 24 
Post-traumatic stress 85 75 20 47 
Weighted average 82 61 22 32 
Source: See Annex 2 
 
Table 2 
Impact on health and employment per person treated  
 
 
 
Extra months healthy Extra months of 
employment per extra 
month of health 
Extra months of 
employment 
 In first 
2 years 
(1) 
In first  
5 years 
(2) 
 
 
(3) 
In first 
2 years 
(4) 
In first  
5 years 
(5) 
Depression 
Phobia 
Obsessive-compulsive disorder 
Panic disorder 
General anxiety disorder 
Post-traumatic stress 
4.63 
12.46 
9.02 
14.21 
4.50 
8.76 
9.55 
27.93 
20.22 
31.85 
7.62 
14.85 
0.14 
0.24 
0.17 
0.14 
0.08 
0.14 
0.65 
3.03 
1.55 
2.04 
0.38 
1.22 
1.33 
6.80 
3.47 
4.57 
0.67 
2.08 
Weighted average 6.49 13.08 0.14 0.99 2.05 
Source:  See Annex 2 
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Table 3 
Employment and IB rates for people aged 16-64 (%) 
 
 
Full-time 
work 
Part-time 
work 
 
Unemployed 
 
Inactive 
 
 
Total 
% who are 
on IB and 
/ or IS 
No mental disorder 55 19 3 23 100   8 
Depression 36 14 4 45 100  42 
Phobia 22 11 6 61 100  54 
Obsessive-compulsive 22 23 3 52 100  42 
Panic disorder 30 20 5 45 100  35 
General anxiety 42 18 4 36 100  24 
Post-traumatic stress 36 14 4 45 100  42 
Weighted average 35 16 4 45 100      38 
Source :  See Annex 2 
 
 
Table 4 
Working days lost due to sickness absence – average per year per worker 
 
No mental disorder 5 
Depression 24 
Phobia 52 
Obsessive-compulsive 34 
Panic disorder 39 
General anxiety 14 
Post-traumatic stress  24 
Weighted average 25 
 Source:  See Annex 2 
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Table 5 
Average costs and benefits per person treated (£) 
(includes only benefits in first 2 years) 
 
Costs 750  
Benefits to society  
Extra output 1,100  
Medical costs saved 300 ? 
Extra QALYs 3,300  
Total 4,700 ? 
Benefits to Exchequer  
IB/IS/HB/CT + Taxes 900  
Medical costs saved 300 ? 
Total 1,200 ? 
                                      Source:  See Annex 2 
 
 
Table 6 
Cumulative reductions in IB/IS and associated savings: selected years 
 
Year Number 
treated in 
year 
Cumulative 
numbers cured 
(and not relapsed 
by end year) 
Reduced 
numbers on 
IB/IS 
Annual 
savings to 
Exchequer* 
(£ billion) 
2010/11 320k 140k 25k 0.23
2013/14 800k 550k 100k 0.88
2016/17 800k 850k 160k 1.43
               Source:  See Annex 2  * Excludes NHS savings 
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Figure 1 
 
 
Source: Fava et al (2004). 
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Annex 1 
Contribution of Mental Illness to Misery 
 
The first sentence in this article can be illustrated from the following analysis of the 
National Child Development Study.  Participants were interviewed as adults at age 41 (in 
1999) and at age 46 (in 2004).  They were asked about their income and about how 
satisfied they were with their lives.  They were also given a 24-item test for mental illness 
(described as a test of psychological malaise). 
To assess the effect of mental illness on life satisfaction, we take life satisfaction 
in 2004 and see how this is affected by mental illness in 1999 (in order to reduce the 
problem that the question on life satisfaction may be tautologically similar to some of the 
questions on mental illness).  We also introduce as another explanatory variable the 
current level of income. 
In both cases the explanatory factors are expressed as dummy variables.  The 
mental illness variable is a dummy which includes only the worst quarter on the tests of 
psychological malaise.  The poverty variable is a dummy which includes only the lowest 
quarter on the income question.  The resulting regression is (with t – statistics) 
 
Life satisfaction = -0.84 Mentally ill – 0.60 Poor 
          (9.4)  (6.4) 
 
The effect of being mentally ill is in this analysis more than that of being poor.  Needless 
to say, the analysis is purely illustrative. 
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Annex 2 
 
Mix of conditions assumed (%) 
Depression: 45;  Phobia: 5;   Obsessive compulsive disorder : 5; 
Panic Disorder: 5;  General anxiety disorder: 30;  Post-traumatic stress disorder: 10. 
These weights are used in all analyses. 
 
Based on ONS, Psychiatric Morbidity Survey, Table 2.7, with an allowance for 
PTSD which is not identified in the PMS but may affect 3.4% of the population.  
Some judgment is exercised. Throughout the analysis the only data used on phobia 
are for social phobia and agoraphobia.  
 
Table 1 
 Based on data in NICE guidelines. Recovery rates denote proportion recovered by 
end of 4 months among those who were retained. Recovery means loss of specified 
diagnosis or reliable and   clinically significant change (when the former is not 
available).  
 
col (4) = col (1) x (col (2) – col (3)) 
 
Table 2  
 Cols (1) + (2) 
 All except depression 
Assume natural recovery rate per 4 months for all people not recovered by 
the end of the treatment period is one half of the rates shown in Table 1 for 
recovery rates during the period. (This is because natural recovery rates are 
higher soon after the onset of illness.  See Bruce et al in American Journal of 
Psychiatry, June 2005.) 
 
 
 
 Depression 
 We assume that, if untreated, depression lasts 9 months. After recovery, 
subsequent health is as shown in Figure 1, with subsequent natural recovery 
occurring again after 9 months. 
 
 Col (3) 
 The Psychiatric Morbidity Survey 2000, shows the employment rates (Ni) of people 
with each disorder i and with no disorder (No) – see Table 3. We assume that, for 
people who had disorder i and now do not, the employment rate increases by 0.6 (No 
- Ni).  
 
 Cols (4) and (5) 
 
 Cols (1) and (2) multiplied by Col (3) – except in the bottom row. 
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Table 3 
 Psychiatric Morbidity Survey.  PTSD is equated to depression 
 
Table 4 
 See Table 3. 
 
Table 5 
  See text.  Output gains allow for increased employment and reduced absenteeism. 
Here again we use the coefficient of 0.6. The estimates of months off IB are based 
on extra months healthy times 0.6 times the difference between IB and / or IS rates 
for ‘ill’ and ‘healthy’ people.21  The estimates of extra taxes are based on extra 
months in work. 
 
Table 6 
 See above assumptions.  Note that the programme is assumed to begin in 2008/9 
 
                                                 
21 This is slightly more than extra months in work times the proportion of mentally-ill inactive people on IB 
and / or IS.  This is because some people are off IB without being in work. 
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